Skip to main navigation
WINDTREE THERAPEUTICS logo

Header Nav

  • Company
    • Company Overview
    • Management
    • Board of Directors
    • Corporate Governance
    • Contact Us
    • Diversity, Inclusion and Innovation
  • Pipeline and Technology
    • Pipeline and Therapeutic Overview
    • Istaroxime
    • SERCA2a Activators
    • Lucinactant (KL4 surfactant)
    • AEROSURF®
    • Rostafuroxin
    • Expanded Access Policy
  • Business Development
  • Investors
    • Welcome
    • Financial Information
      • IR Snapshot
      • Annual Reports
    • Financial Fundamentals
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
    • Filings
      • SEC Filings
      • Ownership
    • Corporate Governance
    • Corporate Presentation
    • Events
    • Press Releases
    • Investor Alerts
  • Contact Us
Select Page

SEC Filing Details

Header Nav

  • Welcome
  • Financial Information
    • IR Snapshot
    • Annual Reports
  • Financial Fundamentals
  • Stock Information
    • Stock Quote & Chart
    • Historic Price Lookup
  • Filings
    • SEC Filings
    • Ownership
  • Corporate Governance
  • Corporate Presentation
  • Events
  • Press Releases
  • Investor Alerts

Toolkit

  • Email Alerts
  • Print Page
  • Share
  • RSS Feeds
  • Contact IR
  • Search

Document Details

Form
8-K/A
Filing Date
Nov 15, 2024
Document Date
Sep 25, 2024
Form Description
Amendment to a previously filed 8-K
Filing Group
Current Reports
Company
Windtree Therapeutics, Inc
Issuer
WINDTREE THERAPEUTICS INC /DE/

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
XML - XBRL INSTANCE DOCUMENT
YM Twitter Feed
© Copyright 2024 Windtree Therapeutics, Inc